232 related articles for article (PubMed ID: 15294075)
1. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
Nishikawa F; Funaji K; Fukuda K; Nishikawa S
Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of RNA aptamers against HCV-NS3 helicase and their structural similarity with 3'(+)UTR of HCV.
Nishikawa S; Nishikawa F; Fukuda K
Nucleic Acids Res Suppl; 2003; (3):241-2. PubMed ID: 14510470
[TBL] [Abstract][Full Text] [Related]
3. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
5. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
6. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
7. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of hepatitis C virus NS3 helicase.
Kwong AD; Kim JL; Lin C
Curr Top Microbiol Immunol; 2000; 242():171-96. PubMed ID: 10592661
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
Tani H; Fujita O; Furuta A; Matsuda Y; Miyata R; Akimitsu N; Tanaka J; Tsuneda S; Sekiguchi Y; Noda N
Biochem Biophys Res Commun; 2010 Feb; 393(1):131-6. PubMed ID: 20117090
[TBL] [Abstract][Full Text] [Related]
10. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.
Hwang B; Cho JS; Yeo HJ; Kim JH; Chung KM; Han K; Jang SK; Lee SW
RNA; 2004 Aug; 10(8):1277-90. PubMed ID: 15247433
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
12. The arginine-1493 residue in QRRGRTGR1493G motif IV of the hepatitis C virus NS3 helicase domain is essential for NS3 protein methylation by the protein arginine methyltransferase 1.
Rho J; Choi S; Seong YR; Choi J; Im DS
J Virol; 2001 Sep; 75(17):8031-44. PubMed ID: 11483748
[TBL] [Abstract][Full Text] [Related]
13. Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.
Hesson T; Mannarino A; Cable M
Biochemistry; 2000 Mar; 39(10):2619-25. PubMed ID: 10704211
[TBL] [Abstract][Full Text] [Related]
14. Analysis of aptamer binding site for HCV-NS3 protease by alanine scanning mutagenesis.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Taira K; Kusakabe I; Nishikawa S
Nucleic Acids Symp Ser; 2000; (44):253-4. PubMed ID: 12903364
[TBL] [Abstract][Full Text] [Related]
15. N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3.
Marecki JC; Aarattuthodiyil S; Byrd AK; Penthala NR; Crooks PA; Raney KD
Bioorg Med Chem Lett; 2019 Feb; 29(3):430-434. PubMed ID: 30578035
[TBL] [Abstract][Full Text] [Related]
16. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3).
Tai CL; Chi WK; Chen DS; Hwang LH
J Virol; 1996 Dec; 70(12):8477-84. PubMed ID: 8970970
[TBL] [Abstract][Full Text] [Related]
17. Structure-based mutagenesis study of hepatitis C virus NS3 helicase.
Lin C; Kim JL
J Virol; 1999 Oct; 73(10):8798-807. PubMed ID: 10482634
[TBL] [Abstract][Full Text] [Related]
18. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
[TBL] [Abstract][Full Text] [Related]
19. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
[TBL] [Abstract][Full Text] [Related]
20. The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.
Aydin C; Mukherjee S; Hanson AM; Frick DN; Schiffer CA
Protein Sci; 2013 Dec; 22(12):1786-98. PubMed ID: 24123290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
